Ticho S. Barry's most recent trade in Stoke Therapeutics Inc was a trade of 10,000 Performance Stock Units done . Disclosure was reported to the exchange on Dec. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 10,000 | 0 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2025 | 10,000 | 25,156 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.35 per share. | 03 Dec 2025 | 1,989 | 19,798 (0%) | 0% | 31.3 | 62,346 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.33 per share. | 03 Dec 2025 | 1,673 | 21,787 (0%) | 0% | 31.3 | 52,416 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.76 per share. | 03 Dec 2025 | 1,373 | 23,783 (0%) | 0% | 30.8 | 42,238 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.32 per share. | 03 Dec 2025 | 323 | 23,460 (0%) | 0% | 31.3 | 10,115 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 11,981 | 19,176 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 11,981 | 0 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.56 per share. | 01 Dec 2025 | 1,244 | 17,932 (0%) | 0% | 29.6 | 36,775 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.85 per share. | 01 Dec 2025 | 1,225 | 15,156 (0%) | 0% | 30.8 | 37,788 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.34 per share. | 01 Dec 2025 | 789 | 16,381 (0%) | 0% | 30.3 | 23,937 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 01 Dec 2025 | 762 | 17,170 (0%) | 0% | 30.1 | 22,968 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.22 per share. | 03 Nov 2025 | 3,776 | 9,350 (0%) | 0% | 25.2 | 95,247 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 03 Nov 2025 | 1,455 | 7,895 (0%) | 0% | 26.0 | 37,860 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 03 Nov 2025 | 600 | 7,295 (0%) | 0% | 27.5 | 16,524 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.35 per share. | 03 Nov 2025 | 100 | 7,195 (0%) | 0% | 29.4 | 2,935 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.64 per share. | 01 Oct 2025 | 5,343 | 13,126 (0%) | 0% | 23.6 | 126,316 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.87 per share. | 02 Sep 2025 | 5,501 | 18,469 (0%) | 0% | 19.9 | 109,325 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 18.24 per share. | 18 Aug 2025 | 2,805 | 23,970 (0%) | 0% | 18.2 | 51,158 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 20,000 | 20,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 10,000 | 26,775 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2025 | 10,000 | 10,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 01 Aug 2025 | 4,504 | 16,775 (0%) | 0% | 12.8 | 57,724 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.63 per share. | 01 Jul 2025 | 4,503 | 21,279 (0%) | 0% | 11.6 | 52,379 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 02 Jun 2025 | 6,471 | 25,782 (0%) | 0% | 10.0 | 64,892 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 02 Jun 2025 | 1,745 | 32,253 (0%) | 0% | 10 | 17,450 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 01 May 2025 | 22,790 | 33,998 (0%) | 0% | 10.0 | 228,543 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 01 May 2025 | 3,841 | 56,788 (0%) | 0% | 10 | 38,410 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 64,000 | 64,000 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 43,000 | 43,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.67 per share. | 18 Mar 2025 | 3,884 | 63,962 (0%) | 0% | 8.7 | 33,674 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.27 per share. | 18 Mar 2025 | 3,333 | 60,629 (0%) | 0% | 8.3 | 27,564 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 13,100 | 57,846 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 13,100 | 26,200 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 10,000 | 67,846 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 10,000 | 30,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 09 Dec 2024 | 2,586 | 44,746 (0%) | 0% | 13.0 | 33,596 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.78 per share. | 06 Dec 2024 | 13,945 | 47,332 (0%) | 0% | 12.8 | 178,182 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2024 | 20,000 | 20,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 10,000 | 10,000 | - | - | Performance Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Dec 2024 | 10,000 | 61,277 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 48,792 | 11,981 | - | - | Restricted Stock Unit (RSU) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 48,792 | 51,277 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 01 Dec 2024 | 10,000 | 51,277 (0%) | 0% | 12.1 | 120,698 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Dec 2024 | 10,000 | 61,277 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.68 per share. | 01 Nov 2024 | 10,000 | 2,485 (0%) | 0% | 12.7 | 126,803 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Nov 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Oct 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 10,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 01 Oct 2024 | 10,000 | 2,485 (0%) | 0% | 12.1 | 120,648 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 10,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 03 Sep 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 14.92 per share. | 03 Sep 2024 | 9,400 | 3,085 (0%) | 0% | 14.9 | 140,236 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.41 per share. | 03 Sep 2024 | 600 | 2,485 (0%) | 0% | 15.4 | 9,245 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 10,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 01 Aug 2024 | 10,000 | 2,485 (0%) | 0% | 14.6 | 145,843 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Aug 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.75 per share. | 01 Jul 2024 | 10,000 | 2,485 (0%) | 0% | 13.7 | 137,458 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Jul 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 10,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 03 Jun 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 10,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.21 per share. | 03 Jun 2024 | 9,897 | 2,588 (0%) | 0% | 15.2 | 150,560 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.78 per share. | 03 Jun 2024 | 103 | 2,485 (0%) | 0% | 15.8 | 1,625 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 May 2024 | 10,000 | 12,485 (0%) | 0% | 0.6 | 6,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.37 per share. | 01 May 2024 | 10,000 | 2,485 (0%) | 0% | 11.4 | 113,653 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.23 per share. | 01 Apr 2024 | 9,426 | 2,485 (0%) | 0% | 13.2 | 124,684 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Apr 2024 | 442 | 11,911 (0%) | 0% | 0.6 | 265 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 442 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 13,100 | 39,300 | - | - | Restricted Stock Units | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 13,100 | 15,585 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 15 Mar 2024 | 4,116 | 11,469 (0%) | 0% | 6.1 | 25,102 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.75 per share. | 01 Mar 2024 | 10,000 | 2,485 (0%) | 0% | 7.7 | 77,469 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 01 Mar 2024 | 5,504 | 12,485 (0%) | 0% | 0.6 | 3,302 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,504 | 80,442 | - | - | Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | S. Ticho Barry | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 4.80 per share. | 01 Feb 2024 | 10,000 | 6,981 (0%) | 0% | 4.8 | 47,991 | Common Stock |
| Stoke Therapeutics Inc | S. Barry Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.74 per share. | 02 Jan 2024 | 10,000 | 16,981 (0%) | 0% | 5.7 | 57,352 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2023 | 107,400 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | S. Barry Ticho | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2023 | 65,600 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry Ticho S. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 60,773 | 60,773 | - | - | Restricted Stock Unit (RSU) | |
| Stoke Therapeutics Inc | Ticho S. Barry | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2023 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.60 per share. | 03 Jul 2023 | 15,000 | 25,895 (0%) | 0% | 10.6 | 158,973 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.13 per share. | 01 Jun 2023 | 15,000 | 40,895 (0%) | 0% | 11.1 | 166,964 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 May 2023 | 653 | 55,895 (0%) | 0% | 10 | 6,530 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 01 May 2023 | 24,967 | 86,758 (0%) | 0% | 10.0 | 249,767 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 01 May 2023 | 24,697 | 56,548 (0%) | 0% | 10.1 | 250,366 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 01 May 2023 | 5,513 | 81,245 (0%) | 0% | 10.0 | 55,134 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 78,600 | 78,600 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 52,400 | 52,400 | - | - | Restricted Stock Unite (RSU) | |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 03 Feb 2023 | 9,235 | 111,725 (0%) | 0% | 10.0 | 92,491 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 03 Feb 2023 | 3,763 | 120,960 (0%) | 0% | 10.0 | 37,745 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 31 Jan 2023 | 5,705 | 124,990 (0%) | 0% | 10.0 | 57,140 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 31 Jan 2023 | 267 | 124,723 (0%) | 0% | 10 | 2,670 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 31 Jan 2023 | 200 | 130,695 (0%) | 0% | 10 | 2,000 | Common Stock |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 107,400 | 107,400 | - | - | Employee Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Barry S. Ticho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.68 per share. | 13 Jul 2021 | 39,866 | 134,195 (0%) | 0% | 32.7 | 1,302,929 | Common Stock |